This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rocha, M. F. Articles by Lima, A. A. Search for Related Content PubMed PubMed Citation Articles by Rocha, M. F. Articles by Lima, A. A.

 Previous Article  |  Next Article 

Infect. Immun., 07 1997, 2740-2746, Vol 65, No. 7
Copyright © 1997, American Society for Microbiology

Clostridium difficile toxin A induces the release of neutrophil chemotactic factors from rat peritoneal macrophages: role of interleukin-1beta, tumor necrosis factor alpha, and leukotrienes

MF Rocha, ME Maia, LR Bezerra, DM Lyerly, RL Guerrant, RA Ribeiro and AA Lima
Department of Physiology and Pharmacology, Health Sciences Center, Federal University of Ceara, Fortaleza-CE, Brazil.

Clostridium difficile produces a potent enterotoxin and cytotoxin, toxins A and B, respectively, which appear to be responsible for pseudomenbranous colitis and antibiotic-associated diarrhea. In the present study we explored the neutrophil migration evoked by toxin A in the peritoneal cavities and subcutaneous air pouches of rats and examined the role of macrophages and their inflammatory mediators in this process. Toxin A causes a significant dose-dependent neutrophil influx into the peritoneal cavity, with a maximal response at 0.1 microg/ml and at 4 h. The depletion of macrophages by peritoneal washing prevents the toxin A-induced neutrophil migration into the peritoneal cavity. In contrast, an increase in macrophages induced by peritoneal injection of thioglycolate amplifies this toxin effect on neutrophil migration. Furthermore, the injection of supernatants from toxin A-stimulated macrophages into the rat peritoneal cavity causes significant neutrophil migration. Pretreatment of rats with BWA4C, nordihydroguaiaretic acid, mepacrine, or dexamethasone inhibits the neutrophil migration evoked by toxin A in the peritoneal cavities. However, pretreatment with the cyclooxygenase inhibitor indomethacin or the platelet-activating factor antagonist BN52021 fails to alter toxin A-induced neutrophil migration. Toxin A was also injected into air pouches of normal rats or rats pretreated with anti-interleukin-1beta (anti-IL-1beta) or anti-tumor necrosis factor alpha (anti-TNF-alpha) antibodies. Anti-TNF-alpha or anti-IL-1beta antibodies significantly reduce the neutrophil migration induced by toxin A. These data suggest that neutrophil migration evoked by toxin A is in part dependent on macrophage-derived cytokines, such as TNF-alpha and IL-1beta, and leukotrienes. These mediators may help to explain the intense inflammatory colitis caused by C. dificile toxin A in an experimental animal model of this disease.

This article has been cited by other articles:

• Meyer, G. K. A., Neetz, A., Brandes, G., Tsikas, D., Butterfield, J. H., Just, I., Gerhard, R. (2007). Clostridium difficile Toxins A and B Directly Stimulate Human Mast Cells. Infect. Immun. 75: 3868-3876 [Abstract] [Full Text]  
• Cavalcante, I. C., Castro, M. V., Barreto, A. R. F., Sullivan, G. W., Vale, M., Almeida, P. R. C., Linden, J., Rieger, J. M., Cunha, F. Q., Guerrant, R. L., Ribeiro, R. A., Brito, G. A. C. (2006). Effect of Novel A2A Adenosine Receptor Agonist ATL 313 on Clostridium difficile Toxin A-Induced Murine Ileal Enteritis.. Infect. Immun. 74: 2606-2612 [Abstract] [Full Text]  
• Carneiro, B. A., Fujii, J., Brito, G. A. C., Alcantara, C., Oria, R. B., Lima, A. A. M., Obrig, T., Guerrant, R. L. (2006). Caspase and Bid Involvement in Clostridium difficile Toxin A-Induced Apoptosis and Modulation of Toxin A Effects by Glutamine and Alanyl-Glutamine In Vivo and In Vitro. Infect. Immun. 74: 81-87 [Abstract] [Full Text]  
• Assreuy, A. M. S., Alencar, N. M.N., Cavada, B. S., Rocha-Filho, D. R., Feitosa, R. F.G., Cunha, F. Q., Calvete, J. J., Ribeiro, R. A. (2003). Porcine Spermadhesin PSP-I/PSP-II Stimulates Macrophages to Release a Neutrophil Chemotactic Substance: Modulation by Mast Cells. Biol. Reprod. 68: 1836-1841 [Abstract] [Full Text]  
• Simeonidis, S., Castagliuolo, I., Pan, A., Liu, J., Wang, C.-C., Mykoniatis, A., Pasha, A., Valenick, L., Sougioultzis, S., Zhao, D., Pothoulakis, C. (2003). Regulation of the NK-1 receptor gene expression in human macrophage cells via an NF-kappa B site on its promoter. Proc. Natl. Acad. Sci. USA 100: 2957-2962 [Abstract] [Full Text]  
• Mazuski, J. E., Grossmann, E. M., Norman, J. G., Denham, W., Panesar, N., Shapiro, M. J., Durham, R. L., Kaminski, D. L., Longo, W. E. (2000). Clostridium difficile Toxins Influence Hepatocyte Protein Synthesis Through the Interleukin 1 Receptor. Arch Surg 135: 1206-1211 [Abstract] [Full Text]  
• Stubbe, H., Berdoz, J., Kraehenbuhl, J.-P., Corthesy, B. (2000). Polymeric IgA Is Superior to Monomeric IgA and IgG Carrying the Same Variable Domain in Preventing Clostridium difficile Toxin A Damaging of T84 Monolayers. J. Immunol. 164: 1952-1960 [Abstract] [Full Text]  
• Jefferson, K. K., Smith, M. F. Jr., Bobak, D. A. (1999). Roles of Intracellular Calcium and NF-{kappa}B in the Clostridium difficile Toxin A-Induced Up-Regulation and Secretion of IL-8 from Human Monocytes. J. Immunol. 163: 5183-5191 [Abstract] [Full Text]  
• Rocha, M. F. G., Soares, A. M., Flores, C. A., Steiner, T. S., Lyerly, D. M., Guerrant, R. L., Ribeiro, R. A., Lima, A. A. M. (1998). Intestinal Secretory Factor Released by Macrophages Stimulated with Clostridium difficile Toxin A: Role of Interleukin 1beta. Infect. Immun. 66: 4910-4916 [Abstract] [Full Text]  
• Calderon, G. M., Torres-Lopez, J., Lin, T.-J., Chavez, B., Hernandez, M., Munoz, O., Befus, A. D., Enciso, J. A. (1998). Effects of Toxin A from Clostridium difficile on Mast Cell Activation and Survival. Infect. Immun. 66: 2755-2761 [Abstract] [Full Text]  
• Kink, J. A., Williams, J. A. (1998). Antibodies to Recombinant Clostridium difficile Toxins A and B Are an Effective Treatment and Prevent Relapse of C. difficile-Associated Disease in a Hamster Model of Infection. Infect. Immun. 66: 2018-2025 [Abstract] [Full Text]